News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
News Conference News ACC 2024 Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI Michael O'Riordan April 07, 2024
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News TCT 2020 No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH L.A. McKeown October 14, 2020
News Conference News ESC 2020 Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY Caitlin E. Cox September 01, 2020
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015
News Daily News Subanálisis del PLATO: Las Hemorragias Graves se asocian a una Mayor Mortalidad a Corto Plazo en el Manejo de los SCA Yael L. Maxwell October 03, 2014
News Daily News PLATO Subanalysis: Major Bleeding Linked With Increased Short-term Mortality in ACS Yael L. Maxwell October 03, 2014
News Daily News PCI Patients More Likely to Die from Noncardiac Causes L.A. McKeown February 12, 2014
News Daily News Los Pacientes PCI son Más Propensos a Fallecer por Causas No Cardíacas L.A. McKeown February 12, 2014
Presentation TCT 2013 Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! Presenter: Philippe Gabriel Steg October 31, 2013
Presentation TCT 2013 Upstream Bivalirudin: Insights from EuroMax Presenter: Philippe Gabriel Steg October 30, 2013
Presentation TCT 2013 STEMI Reperfusion Pathways and Systems of Care: Global Report Card Presenter: Philippe Gabriel Steg October 30, 2013
Presentation TCT 2013 Guideline Strategies for Antithrombotic Therapy in ACS: Contrasting the European and US Perspectives Presenter: Philippe Gabriel Steg October 30, 2013
Presentation TCT 2013 Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI... Presenter: Philippe Gabriel Steg October 30, 2013
News Conference News TCT 2013 EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI October 30, 2013
News Conference News ESC 2013 PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times September 03, 2013